Mechanisms and Predictions of Drug-Drug Interactions of the Hepatitis C Virus Three Direct-Acting Antiviral Regimen: Paritaprevir/Ritonavir, Ombitasvir, and Dasabuvir-Reference-Cited by-同舟云学术

Mechanisms and Predictions of Drug-Drug Interactions of the Hepatitis C Virus Three Direct-Acting Antiviral Regimen: Paritaprevir/Ritonavir, Ombitasvir, and Dasabuvir

Published:2017-05-08 Issue:7 Volume:45 Page:755-764
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Shebley Mohamad,Liu Jinrong,Kavetskaia Olga,Sydor Jens,de Morais Sonia M.,Fischer Volker,Nijsen Marjoleen J.M.A.,Bow Daniel A.J.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference33 articles.

1. Pharmacokinetics and Dose Recommendations for Cyclosporine and Tacrolimus When Coadministered With ABT‐450, Ombitasvir, and Dasabuvir

2. Prediction of in vivo drug-drug interactions from in vitro data: impact of incorporating parallel pathways of drug elimination and inhibitor absorption rate constant

3. Clinical management of drug–drug interactions in HCV therapy: Challenges and solutions

4. In vitroOATP1B1 and OATP1B3 inhibition is associated with observations of benign clinical unconjugated hyperbilirubinemia

5. Hepatic OATP and OCT uptake transporters: their role for drug-drug interactions and pharmacogenetic aspects

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. No dose adjustment of metformin or substrates of organic cation transporters (OCT)1 and OCT2 and multidrug and toxin extrusion protein (MATE)1/2K with fostemsavir coadministration based on modeling approaches;Pharmacology Research & Perspectives;2024-07-10

2. A review on dynamics of permeability-glycoprotein in efflux of chemotherapeutic drugs;Frontiers in Drug Discovery;2024-04-11

3. Mechanistic Determinants of Daprodustat Drug–Drug Interactions and Pharmacokinetics in Hepatic Dysfunction and Chronic Kidney Disease: Significance of OATP1B‐CYP2C8 Interplay;Clinical Pharmacology & Therapeutics;2024-02-26

4. HCV Antiviral Drugs Have the Potential to Adversely Perturb the Fetal-Maternal Communication Axis through Inhibition of CYP3A7 DHEA-S Oxidation;Drug Metabolism and Disposition;2024-01-24

5. OATP Transporters in Hepatic and Intestinal Uptake of Orally Administered Drugs;Oral Bioavailability and Drug Delivery;2023-10-10